Strength Seen in Cynosure (CYNO): Stock Rises 6.7% – Tale of the Tape

January 9, 2015 Technicals 0

Zacks

Cynosure, Inc. (CYNO) was a big mover last session with its shares rising nearly 9% on the day. The upside was a result of Brean Capital’s coverage initiation on the company with a Buy rating. This development led to far more shares changing hands yesterday than in a normal session. The day’s move breaks the recent trend of the company as the stock is now trading above the volatile price range of $27.42 to $29.33 since Dec 10.

This manufacturer of aesthetic treatment systems for the dermatology, plastic surgery, and general medical markets has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cynosure currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the medical instruments industry is ABIOMED, Inc. (ABMD) with a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply